Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results forPINK:RHHBY
35.48
+0.14 (0.39%)
After Hours: 35.48 0.00 (0.00%)
Jan 26, 4:37pm GMT-5  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 35.40 - 35.62
52 week 33.23 - 38.71
Open 35.52
Vol / Avg. 937,533.00/2.23M
Mkt cap 247,976.67M
P/E 20.04
Div/yield 1.11/3.13
EPS 1.77
Shares 689.39M
Beta 0.65
Inst. own 15%
Apr 22, 2015
Q1 2015 Roche Holding AG Corporate Sales Release - 1:00am GMT-4 - Add to calendar
Apr 22, 2015
Q1 2015 Roche Holding AG Corporate Sales Call Add to calendar
Mar 27, 2015
Roche Holding AG at Kepler Cheuvreux Swiss Conference Add to calendar
Mar 18, 2015
Roche Holding AG at Exane Bnp Healthcare Conference Add to calendar
Mar 4, 2015
Roche Holding AG at Cowen Health Care Conference Add to calendar
Mar 3, 2015
Roche Holding AG Annual Shareholders Meeting Add to calendar
Jan 28, 2015
Full Year 2014 Roche Holding AG Earnings Call - 10:00am GMT-5 - Add to calendar
Jan 28, 2015
Full Year 2014 Roche Holding AG Earnings Release - 1:00am GMT-5 - Add to calendar
Jan 16, 2015
Roche Holding AG at Helvea Swiss Equities Conference
Jan 15, 2015
Roche Holding AG at Bellevue Meets Management Seminar
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 24.55% 24.31%
Operating margin 35.48% 34.99%
EBITD margin - 41.93%
Return on average assets 18.13% 17.91%
Return on average equity 60.12% 66.04%
Employees 81,769 -
CDP Score - 96 B

Address

Grenzacherstr. 124
BASEL, 4070
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. It operates worldwide containing the United States, Western Europe, Japan and Asia-Pacific, among others. Diagnostics include five areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan. In September 2014, it accepted for payment of all shares of InterMune Inc. through its wholly owned subsidiary Klee Acquisition Corporation. Additionally, it offers hardware and software solutions for genomic analysis.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Director
Age: 47
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 47
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 52
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Age: 50
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
Age: 67
John C. Reed M.D., Ph.D. Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 56
Richard H. Scheller Ph.D. Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 61
Urs Jaisli Chief Compliance Officer
Age: 58
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 60
Silvia Ayyoubi Member of the Corporate Executive Committee, Head of Group Human Resources
Age: 61